HealthMore in Health→
Drug tariff threats are forcing pharma to rethink trade exposure and pricing strategy
A new STAT report says the Trump administration announced 100% tariffs on imported brand-name drugs, with significant caveats that could reshape industry strategy without creating a clean break from global supply chains.
Key Takeaways
- STAT says the Trump administration announced 100% tariffs on imported brand-name drugs.
- The report stresses that the tariffs come with significant caveats.
DE
DT Editorial Team··via statnews.com